Bosnian drug maker Bosnalijek net profit plummets


Bosnian pharmaceuticals maker Bosnalijek said on Friday its net profit plummeted 62.4% on the year to 1.2 million KM (613,500 euro) in the first six months of 2016.

Operating income dropped 1.3% to 46.4 million KM in the six months through June, while operating costs climbed 6% to 44.8 million KM, Bosnalijek said in a filing with the Sarajevo Stock Exchange.

In 2015 Bosnalijek's net profit amounted to 11.2 million marka, as operating revenue jumped 6% on the year to 126.9 million KM.